Discuss the current model for vaccine distribution and the parameters that this sets to global supply networks
Examine the application of Cryo solutions for ATMP based supply chains and vaccine supply chains and what technologies and partnerships can be leveraged for a fast turnaround vaccine network
Benchmark strategies for both Cryo and cold chain global network development that are both efficient – in terms of both cost and time - and scalable
Saddam Huq
Global QA Senior Manager, Distribution & Cold Chain GSK Vaccines
Discuss the challenges for ATMP supply chains given product sensitivity and shipping requirements
Examine the parameters of ‘lean and efficient global supply’ for Cryo shipments: why is it different to cool chain and what do we need from the technology providers?
Hear how Pluristem have achieved the capability to deliver products globally and compliantly in only 4 hours
Lior Raviv
Vice President Of Development Pluristem Therapeutics
We use cookies and similar technologies to recognize your visits and preferences, as well as to measure the effectiveness of campaigns and analyze traffic. To learn more about cookies, including how to disable them, view our Cookie Policy
Unsupported Browser Detected
The browser you are using is not supported that will prevent you from accessing certain features of the website. We want you to have the best possible experience. For this you'll need to use a supported browser and upgrade to the latest version.